275 related articles for article (PubMed ID: 14689061)
41. T-cell qualities of lymphocytes and/or leukemic cells from peripheral blood in acute myeloid and lymphatic leukemia before treatment and at relapse.
de Vaan GA; Bakkeren JA; Schretlen ED
Biomedicine; 1975 Nov; 22(6):524-31. PubMed ID: 1083749
[TBL] [Abstract][Full Text] [Related]
42. Expression of the protooncogenes c-myc, c-fos, and c-fms in acute myelocytic leukemia at diagnosis and in remission.
Preisler HD; Kinniburgh AJ; Wei-Dong G; Khan S
Cancer Res; 1987 Feb; 47(3):874-80. PubMed ID: 2433029
[TBL] [Abstract][Full Text] [Related]
43. Argyrophilic proteins of the nucleolar organizer region in acute leukemias and its relation to the S-phase fraction of leukemic cells.
Nakamura S; Takeda Y; Okabe Y; Yoshida T; Ohtake S; Kobayashi K; Kanno M; Matsuda T
Acta Haematol; 1992; 87(1-2):6-10. PubMed ID: 1374991
[TBL] [Abstract][Full Text] [Related]
44. [The prognostic significance of the differential blood count in patients with chronic myeloid leukemia].
Zankovich R; Schilling H; Thiele J; Kvasnicka HM; Diehl V
Med Klin (Munich); 1989 Aug; 84(8):373-7. PubMed ID: 2796866
[TBL] [Abstract][Full Text] [Related]
45. Variations in the occurrence of silver-staining nucleolar organizer regions (AgNORs) in non-proliferating and proliferating tissues.
Leek RD; Alison MR; Sarraf CE
J Pathol; 1991 Sep; 165(1):43-51. PubMed ID: 1955934
[TBL] [Abstract][Full Text] [Related]
46. Specific xenogenous antiserum to cells of chronic myeloid leukemia (CML) in blastic crisis.
Baryshnikov AJ; Radzikhovskaya RM; Morozova LF; Belyanchikova NI; Slavina EG; Vinogradova JE; Mkheidze DM; Polotskaya TM; Volkova MA; Svet-Moldavsky GJ; Nikitin VD; Kutimov VA; Trubitsina VI; Goletsky SA; Glazunov A
Biomedicine; 1976 Dec; 25(9):316-7. PubMed ID: 1069594
[TBL] [Abstract][Full Text] [Related]
47. Argyrophilic nucleolar organiser region (AgNOR) staining in normal bone marrow cells.
Nikicicz EP; Norback DH
J Clin Pathol; 1990 Sep; 43(9):723-7. PubMed ID: 1698824
[TBL] [Abstract][Full Text] [Related]
48. [Characteristics of the silver-stained nucleoli in blast elements of various diameters from patients with acute leukemia].
Mamaev NN; Martinez H; Morozova EO; Ivanova NA
Tsitologiia; 1988 Dec; 30(12):1478-82. PubMed ID: 2470179
[TBL] [Abstract][Full Text] [Related]
49. Increased leukotriene C4 production in chronic myelogenous leukemia.
Stenke L; Reizenstein P; Lindgren JA
Acta Oncol; 1988; 27(6b):803-5. PubMed ID: 2852946
[TBL] [Abstract][Full Text] [Related]
50. Prolonged T1 relaxation of the hemopoietic bone marrow in patients with chronic leukemia.
Jensen KE; Sørensen PG; Thomsen C; Christoffersen P; Henriksen O; Karle H
Acta Radiol; 1990 Sep; 31(5):445-8. PubMed ID: 2261287
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of S-phase white blood cell count in B-cell chronic lymphocytic leukemia.
Orfao A; Ciudad J; González M; San Miguel JF; García AR; López-Berges MC; Ramos F; Del Cañizo MC; Ríos A; Sanz M
Leukemia; 1992 Jan; 6(1):47-51. PubMed ID: 1736013
[TBL] [Abstract][Full Text] [Related]
52. [HLA and leukemia].
Baldauf C; Kubel M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):123-32. PubMed ID: 2472315
[TBL] [Abstract][Full Text] [Related]
53. Specificities of heterologous antisera against human leukaemia cells. 1. Reactions against leukaemia cells.
Thränhardt H; Milleck J; Zintl F; Koppitz D; Plenert W; Raderecht C; Richter KV
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):463-74. PubMed ID: 83265
[TBL] [Abstract][Full Text] [Related]
54. [Outcome of patients with primary malignant lymphoma of the brain; relationship to the nucleolar organizer region].
Nakasu S; Nakazawa T; Saito A; Matsuda M; Handa J
No Shinkei Geka; 1992 May; 20(5):593-8. PubMed ID: 1598135
[TBL] [Abstract][Full Text] [Related]
55. Interferon production in myelo- and lymphoproliferative diseases. I. Spontaneous interferon production in acute and chronic leukaemias.
Szabó B; Tóth FD; Kiss J; Váczi L; Kiss A; Rák K
Acta Microbiol Hung; 1988; 35(3):295-300. PubMed ID: 2465655
[TBL] [Abstract][Full Text] [Related]
56. [Determination of T lymphocyte subpopulations in malignant lymphoproliferative diseases].
Milosević D; Marinković M; Suvajdzić N; Spuzić I
Glas Srp Akad Nauka Med; 1991; (41):105-11. PubMed ID: 1916436
[TBL] [Abstract][Full Text] [Related]
57. [Cytometric study of blast cells in acute leukemias and their prognostic value].
Stefanović N
Med Pregl; 1992; 45(7-8):253-7. PubMed ID: 1344451
[TBL] [Abstract][Full Text] [Related]
58. [Analysis of DNA aneuploidy as a tumor marker].
Takamoto S
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2329-37. PubMed ID: 2751314
[TBL] [Abstract][Full Text] [Related]
59. Differential nucleolus organizer activity in normal and leukemic bone marrow.
Arden KC; Johnston DA; Cork A; Pathak S
Am J Hematol; 1989 Mar; 30(3):164-73. PubMed ID: 2464925
[TBL] [Abstract][Full Text] [Related]
60. Human leukaemia-associated antigens expressed by acute myelocytic leukaemia cells and their detection by heterologous antisera.
Thränhardt H; Milleck J; Zintl F; Koppitz D; Plenert W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(3):311-20. PubMed ID: 89982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
